Cannabis Science CFO Speaks at a Conference Sponsored By the Mexican Congress, A Political Debate on the Regulation of the Cannabis Plant in Mexico
SAN FRANCISCO--(BUSINESS WIRE)--Cannabis Science Inc. (OTCBB: GFON.OB): Mr. Richard Cowan, Chief Financial Officer, reported to the Board following his successful presentation to the Legislative Prospects and Public Policy on Cannabis Conference sponsored by the Mexican Congreso de la UniÃ³n last week. Mr. Cowans panels presentation brought the conference to a close on April 15, 2009, the day before U.S. President Barack Obama's meeting with Mexican President Felipe Calderon in preparation for the 2009 Summit of the Americas. The three-day conference, held in the magnificent Mexican Congressional Building in Mexico City from April 13 to 15, covered a broad range of cannabis issues, including medical and industrial use.
Cowan stated, "There is a global demand for pharmaceutical cannabis products being developed by CSI as a result of new scientific discoveries. We strongly believe that these new discoveries will help the Obama Administration move forward with the Federal approval of Medical Cannabis to treat a wide variety of diseases, including cancer, bird flu, and neuromuscular disorders, as well as chronic pain and autoimmune disorders."
Please visit Mr. Cowan's website www.MarijuanaNews.com for a complete report on the conference.
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
About The Cannabis Science 420 Commemorative Certificate Program
April 20th is a special holiday when cannabis patients and advocates around the world celebrate the benefits of this unique medicinal herb. To commemorate this special holiday we have now officially launched our Cannabis Science Inc., 420 Commemorative Certificate Program. Please visit www.cannabisscience.com for more information.
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," "intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.